Has Daniel Holzwanger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,733 in general payments to Daniel Holzwanger, MD across 105 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Holzwanger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Holzwanger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Holzwanger, MD

Vascular & Interventional Radiology · New York, NYNPI 1326481144

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Guerbet LLC at 57.9% of the total. 2025 is the largest year on record at $18,763, more than ten times the $505 reported in 2019.

$28,733in general payments, 2019–2025

Across 105 payments — averaging $273.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Guerbet LLC$17K
Inari Medical, Inc.$5K
Balt USA, LLC$1K
Penumbra, Inc.$854
Argon Medical Devices, Inc.$848
Nevro Corp.$572
plus $3K from 16 others

$27,613in research payments, 2019–2025

Across 2 payments — averaging $13,806 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Angiodynamics, Inc.$28K

What the payments were for

Consulting fees$10,95838%
Travel & lodging$11,65741%
Food & beverage$6,11821%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Guerbet LLC	4	$16,637
Inari Medical, Inc.	15	$5,377
Balt USA, LLC	18	$1,482
Penumbra, Inc.	13	$854
Argon Medical Devices, Inc.	22	$848
Nevro Corp.	3	$572
GE HealthCare	1	$500
Stryker	3	$349
Relievant Medsystems, Inc.	2	$325
Cook Medical LLC	2	$308
Medtronic	4	$214
Avanos Medical	2	$201
Abbott	1	$183
Galvanize Therapeutics, Inc	3	$173
Boston Scientific	3	$172
Angiodynamics, Inc.	1	$144
Siemens Medical Solutions USA, Inc.	2	$126
Terumo Medical Corporation	1	$125
Trisalus Life Sciences, Inc.	2	$75
MML US, Inc.	1	$26
Bard Peripheral Vascular, Inc.	1	$20
SPR Therapeutics, Inc	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Lipiodol$7,679
FLOWTRIEVER CATHETER, S$4,790
CT THROMBECTOMY SYSTEM KIT$4,790
Intracept$1,000
Prestige Coil System$811
Senza$572
OEC$500
Optima Coil System$351
Indigo System$298
Cook$225
Perclose ProGlide suture mediated closure system$183
AUGMENT INJECTABLE$175
IVS - VERTEBRAL AUGMENTATION PRODUCTS$159
RUBY Coil$150
ALIYA SYSTEM$140
Revere Hybrid Access Catheter$134
Penumbra Ruby Coil$133
POD$133
COOLIEF* COOLED RADIOFREQUENCY$130
HydroPearl$125

How this compares

$28,733 in reported general payments places this provider in the 85th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York →

Medicare billing

Part B allowed, 2024

$44,177

Medicare patients

117

Services billed

1,337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New York

Edward KimNew York$831K
Robert LooksteinNew York$515K
Rahul PatelNew York$275K
Aaron FischmanNew York$240K
Philip MeyersNew York$238K
Abigail FalkNew York$214K
Robert RosenNew York$199K
Asad BaigNew York$137K
Joshua WeintraubNew York$137K
Joseph ShamsNew York$136K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →